Cn1c(=O)c2c(nc(NN/C=C3/C(=O)NC(=S)N(C4CCCCC4)C3=O)n2C)n(C)c1=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?